Synerkine Pharma raised €5.3M in a Series A round in Oct 2023. The company is based in Utrecht, Netherlands. Investors in the round: Flerie Invest, InnovationQuarter Capital, Thuja Capital and 1 other. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €5.3M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.